APAC Pen Needles market Size & Growth (2019 – 2024)
The Pen needles market size in Asia Pacific region is expected to reach USD 0.76 billion by 2024 from USD 0.4 billion in 2019, growing at a CAGR of 14.10% for the next five years 2019-2024.
Pen needles are used to deliver the medication (such as insulin or other injectable medications) in combination with injection pens. A pen needle comprises a hollow needle attached to an injection pen. Pen needles are available with varied needle lengths and are majorly utilized by diabetes patients.
Quickly rising diabetic population, a growing number of awareness programs on diabetes conditions, and increasing adoption of pen devices for insulin delivery are driving the growth of the pen needles market in the Asia-Pacific region. However, increasing the reuse of pen needles, limited acceptance of diabetic patients towards the pen needles, and higher cost of the pen needles as compared to conventional syringes & vials are restraining the growth of the Asia-Pacific pen needles market.
This research report segmented and sub-segmented into the following categories:
By Therapy: Insulin Therapy, GLP-1 Therapy & Growth Hormone Therapy
Based on therapy, insulin therapy is estimated to command the largest share of the Asia-Pacific pen needles market in 2018 and expected to grow at the highest CAGR during the forecast period.
By Type: Standard Needle, Safety Needle
Based on type, the standard pen needle segment is estimated to account for larger share of the Asia-Pacific pen needles market in 2018, whereas safety pen needles segments are estimated to grow at a higher CAGR for the next five years.
By Needle Length: 4mm, 6mm, 8mm, 10mm, 12mm
Among the length of pen needles, 8mm is estimated to command for the largest share of the Asia-Pacific pen needles market in 2018 and 4mm is expected to grow at the highest CAGR during the forecast period.
By Mode of Purchase: Retail, Non-Retail
Based on the mode of purchase retail purchase mode is estimated to account for larger share of the Asia-Pacific pen needles market in 2018 and expected to grow at a higher CAGR for the next five years.
By Country: India, China, Japan, South Korea, Australia, New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore and Rest of APAC
On the basis of region, Japan is estimated to account for the largest share of the Asia-Pacific pen needles market in 2018, whereas India is estimated to grow at the highest CAGR during the forecast period.
Prominent companies dominating the APAC Pen Needles market:
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3.1 Executive Summary
3.2 Key Inferences
3.3 New Developments
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5.1 Therapy
5.1.1 Introduction
5.1.2 Insulin Therapy
5.1.3 GLP-1 Therapy Growth Hormone Therapy
5.1.4 Growth Hormone Therapy
5.2 Type
5.2.1 Introduction
5.2.2 Standard Needle
5.2.3 Safety Needle
5.3 Needle Length
5.3.1 Introduction
5.3.2 4mm
5.3.3 6mm
5.3.4 8mm
5.3.5 10mm
5.3.6 12mm
5.4 Mode of Purchase
5.4.1 Introduction
5.4.2 Retail
5.4.3 Non-Retail
6.3 Asia-Pacific
6.1 Introduction
6.2 China
6.3 India
6.4 Japan
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.1 Becton, Dickinson and Company (U.S.)
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Strategic Evaluation and Operations
8.1.4 Financial analysis
8.1.5 Legal issues
8.1.6 Recent Developments
8.1.7 SWOT analysis
8.1.8 Analyst View
8.2 Novo Nordisk A/S (Denmark)
8.3 Ypsomed Holding AG (Switzerland)
8.4 UltiMed, Inc. (U.S.)
8.5 Allison Medical, Inc. (U.S.)
8.6 Owen Mumford, Ltd. (U.K.)
8.7 B. Braun Melsungen (Germany)
8.8 Artsana S.p.a. (Italy)
8.9 HTL-STREFA S.A. (Poland)
8.10 Terumo Corporation (Japan)
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10.1 Market Outlook
10.2 Investment Opportunities
Appendix
Related Reports
